Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Multicenter Stratified Study Evaluating the Efficacy and Toxicity of Sorafenib in Treating Locally Advanced or Metastatic Angiosarcomas That Are Not Accessible to Curative Surgery

NCT00874874 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT00874874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00874874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Multicenter Stratified Study Evaluating the Efficacy and Toxicity of Sorafenib in Treating Locally Advanced or Metastatic Angiosarcomas That Are Not Accessible to Curative Surgery
Lead sponsor
Centre Oscar Lambret
Phase
Phase 2
Overall status
Completed
Start date
May 23, 2008
Completion date
May 23, 2018
Enrollment
88 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma